226 related articles for article (PubMed ID: 23002358)
1. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
Buttar NS; Wang KK; Leontovich O; Westcott JY; Pacifico RJ; Anderson MA; Krishnadath KK; Lutzke LS; Burgart LJ
Gastroenterology; 2002 Apr; 122(4):1101-12. PubMed ID: 11910360
[TBL] [Abstract][Full Text] [Related]
3. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats.
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T; Koichi M
Carcinogenesis; 2005 Mar; 26(3):565-70. PubMed ID: 15564290
[TBL] [Abstract][Full Text] [Related]
4. Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model.
Esquivias P; Cebrián C; Morandeira A; Santander S; Ortego J; García-González MA; Lanas A; Piazuelo E
Oncol Rep; 2014 Jun; 31(6):2785-91. PubMed ID: 24737143
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the prostaglandin E2 pathway in a rat model of esophageal adenocarcinoma.
Piazuelo E; Santander S; Cebrián C; Jiménez P; Pastor C; García-González MA; Esteva F; Esquivias P; Ortego J; Lanas A
Curr Cancer Drug Targets; 2012 Feb; 12(2):132-43. PubMed ID: 22165968
[TBL] [Abstract][Full Text] [Related]
7. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide].
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1183-91. PubMed ID: 17675820
[TBL] [Abstract][Full Text] [Related]
8. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
9. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
Zhang T; Su LW; Zhu YF; Lang HJ; Zhang F; Zhou YA; Liang XH; Wang YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.
Shirvani VN; Ouatu-Lascar R; Kaur BS; Omary MB; Triadafilopoulos G
Gastroenterology; 2000 Mar; 118(3):487-96. PubMed ID: 10702199
[TBL] [Abstract][Full Text] [Related]
11. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibition in esophagitis, Barrett's esophagus and esophageal cancer.
Piazuelo E; Jimenez P; Lanas A
Curr Pharm Des; 2003; 9(27):2267-80. PubMed ID: 14552327
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs.
Black SC; Brideau C; Cirino M; Belley M; Bosquet J; Chan CC; Rodger IW
J Cardiovasc Pharmacol; 1998 Nov; 32(5):686-94. PubMed ID: 9821840
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.
Taddei A; Fabbroni V; Pini A; Lucarini L; Ringressi MN; Fantappiè O; Bani D; Messerini L; Masini E; Bechi P
Dig Dis Sci; 2014 May; 59(5):949-57. PubMed ID: 24357184
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A in Barrett's carcinogenesis.
Rugge M; Fassan M; Zaninotto G; Pizzi M; Giacomelli L; Battaglia G; Rizzetto C; Parente P; Ancona E
Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Woodall CE; Li Y; Liu QH; Wo J; Martin RC
Anticancer Drugs; 2009 Jul; 20(6):437-43. PubMed ID: 19398904
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.
Piazuelo E; Cebrián C; Escartín A; Jiménez P; Soteras F; Ortego J; Lanas A
World J Gastroenterol; 2005 Dec; 11(47):7436-43. PubMed ID: 16437713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
